Hugh S. Markus (United Kingdom)

Cambridge University Clinical Neurosciences
Hugh Markus is Professor of Stroke Medicine and Honorary Consultant Neurologist in the Department of Clinical Neurosciences at the University of Cambridge, UK. After his training he was appointed Senior Lecturer and then Reader in Neurology at King’s College London. He then moved to Professor of Neurology at St George’s, University of London, before moving to his current post in 2013. He spends approximately half of his time in clinical care of stroke patients, including hyperacute stroke care as well as specialist stroke interests including running a National CADASIL Clinic. His research applies genetic and imaging techniques to investigate the pathogenesis of stroke and develop new treatments. He also has an interest in carotid and vertebral artery disease, having carried out studies developing risk prediction using asymptomatic emboli detection in carotid disease, and as Chief Investigator for the VIST trial.

Author Of 3 Presentations

How to Get a Paper Published: An Insiders Guide to What Goes on in the Editors Office

Session Type
Workshop
Date
28.10.2021, Thursday
Session Time
08:00 - 09:30
Room
WORKSHOPS
Lecture Time
08:00 - 08:23

REGRESSION OF WHITE MATTER HYPERINTENSITY LESIONS IN CEREBRAL SMALL VESSEL DISEASE

Session Type
Free Communication Session
Date
28.10.2021, Thursday
Session Time
15:45 - 17:15
Room
FREE COMMUNICATIONS A
Lecture Time
16:25 - 16:35

Abstract

Background and Aims

White matter hyperintensities (WMHs) are a radiological hallmark of cerebral small vessel disease (SVD). Previous studies have found that whole brain WMH burden can reduce over time, but the extent of lesion regression and the factors that drive it are not fully understood. We aimed to assess WMH regression in three SVD cohorts.

Methods

Participants were from the SCANS observational study (n=99; MRI at 0/1/2/3 years) and the PRESERVE trial (intensive blood pressure lowering in SVD; standard treatment arm n=42; MRI at 0/1 year) and had symptomatic lacunar infarcts with moderate WMH burden at baseline (Fazekas score>=2). WMHs in SCANS were calculated using a two-step pipeline mapping individual images to a participant average and then warping to a group average space. WMHs in PRESERVE were calculated using a semi-automatic contouring program with pre- and post-treatment FLAIR images marked in parallel (blinded to timepoint). Regression was defined as WMH reduction >0.25cc between scans.

Results

WMH volume at baseline in SCANS was 45.8cc and the mean change between scans was 4.5+/-6.3cc; no subjects showed regression. WMH at baseline in PRESERVE was 31.0cc and the mean change between scans was 5.9+/-6.0cc); 6 subjects showed regression. Compared to non-regressors there were no significant differences in age, sex, baseline WMH volume, lacune number or brain volume.

Conclusions

Few participants showed WMH regression. To test whether this is due to statistical/imaging factors or SVD severity, we will apply the method used to quantify WMHs in PRESERVE to a third cohort with less severe SVD - the RUN-DMC study (n=276).

Hide

PILOT STUDY OF VISUALISATION OF LENTICULOSTRIATE ARTERIES AT ULTRAHIGH-FIELD 7 TESLA MAGNETIC RESONANCE IMAGING: THE CAMSVD STUDY

Session Type
Oral Presentations
Date
27.10.2021, Wednesday
Session Time
07:00 - 07:30
Room
ORAL PRESENTATIONS 2
Lecture Time
07:30 - 07:40

Abstract

Background and Aims

Ultrahigh-field strength 7 Tesla (7T) MRI provides a high signal to noise ratio which allows higher spatial resolution imaging and consequently its availability, for the first time allows visualisation of the very small perforating (Lenticulostriate, LSA) arteries non-invasively in humans. Using Time-of-Flight MR angiography technique, 7T MRI can be used to obtain angiographic imaging of these small cerebral vessels. The aim of this study was to visualize LSA arising from the Middle Cerebral and Anterior Cerebral arteries using ToF MRA at 7T.

Methods

Pilot study of 5 healthy subjects (mean age 39.4±19.2 years) with no history of neurological disease or vascular pathology who underwent 3D ToF MRA technique on a whole-body human 7T MR system equipped with a 32-channel receive coil. Set protocols were modified in between subject scans to achieve the best possible resolution, with scan time of 10 minutes. LSAs were identified on axial and coronal maximum intensity projections of 15mm thickness.

Results

The images showed good contrast between the LSAs and the background. On average, 5.0±1.2 stems and 7.2±1.5 branches of LSAs were visualized on both left and right sides. Across all LSAs identified, mean length was 22.6±9.9 mm. 3D volume rendered images of the ToF MRA (image) was used to ensure landmarks and confirm LSA origin.

3d rendering tof mra showing lsas.jpg

Conclusions

This pilot study shows our ability to visualise LSAs using 7T ToF MRA. This technique can be exploited in understanding the underlying arterial pathology in patients with lacunar infarcts caused by cerebral small vessel disease stroke.

Clinical Trail Registration: https://clinicaltrials.gov/ct2/show/NCT04330222

Hide

Presenter of 1 Presentation

How to Get a Paper Published: An Insiders Guide to What Goes on in the Editors Office

Session Type
Workshop
Date
28.10.2021, Thursday
Session Time
08:00 - 09:30
Room
WORKSHOPS
Lecture Time
08:00 - 08:23

Moderator of 2 Sessions

Session Type
Workshop
Date
28.10.2021, Thursday
Session Time
08:00 - 09:30
Room
WORKSHOPS
Session Icon
Live Session
Session Type
Main Theme Symposium
Date
28.10.2021, Thursday
Session Time
17:45 - 19:15
Room
MAIN THEME A
Session Icon
Live Session